Literature DB >> 15492832

Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells.

Unmesh Jadhav1, Srinivasulu Chigurupati, Sajani S Lakka, Sanjeeva Mohanam.   

Abstract

The expression of matrix metalloproteinases (MMPs), particularly MMP-9, is significantly increased during tumor progression and is thought to play a major role in mediating angiogenic process. Since microvasculature plays an important role in controlling tumor growth, we investigated the effects of MMP-9 inhibition on endothelial cell migration and tube formation, two determinants of angiogenesis. Adenoviral-mediated MMP-9 downregulation inhibited endothelial cell migration in cell wounding and spheroid migration assays. To determine the effects of MMP-9 reduction in glioblastoma/endothelial co-cultures, we used a three-dimensional co-culture assay of glioblastoma spheroids and endothelial spheroids. Untreated controls showed invasion of both cell populations into each other whereas treatment of the co-cultures with adenoviral antisense MMP-9 particles resulted in reduced invasion. Next, inhibition of MMP-9 by adenoviral vectors in endothelial cells was assessed for in vitro capillary-like structure formation either by co-culture with glioblastoma cells or exposure to glioblastoma-conditioned medium. Addition of conditioned medium from human glioblastoma cells to endothelial cells treated with antisense MMP-9 adenoviral vectors or co-cultures of glioblastoma cell lines with MMP-9-reduced endothelial cells resulted in reduced capillary-like tube formation demonstrating the key role of MMP-9 in endothelial cell network organization. Examination of in vitro capillary-like tube structure formation using Matrigel showed a significant decrease in MMP-9 downregulated endothelial cells as compared to controls. In conclusion, the inhibition of MMP-9 is required for inhibition of endothelial cell migration and tube formation and is likely to be of importance in cerebral angiogenesis for therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492832

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  31 in total

1.  Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.

Authors:  Diana Matias; Joana Balça-Silva; Luiz Gustavo Dubois; Bruno Pontes; Valéria Pereira Ferrer; Luciane Rosário; Anália do Carmo; Juliana Echevarria-Lima; Ana Bela Sarmento-Ribeiro; Maria Celeste Lopes; Vivaldo Moura-Neto
Journal:  Cell Oncol (Dordr)       Date:  2017-04-11       Impact factor: 6.730

2.  Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process.

Authors:  Ravesanker Ezhilarasan; Indra Mohanam; Kathiravan Govindarajan; Sanjeeva Mohanam
Journal:  Int J Oncol       Date:  2007-03       Impact factor: 5.650

Review 3.  Biomimetic Approaches for Bone Tissue Engineering.

Authors:  Johnathan Ng; Kara Spiller; Jonathan Bernhard; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part B Rev       Date:  2017-01-18       Impact factor: 6.389

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

5.  The role of macrophage phenotype in vascularization of tissue engineering scaffolds.

Authors:  Kara L Spiller; Rachel R Anfang; Krista J Spiller; Johnathan Ng; Kenneth R Nakazawa; Jeffrey W Daulton; Gordana Vunjak-Novakovic
Journal:  Biomaterials       Date:  2014-02-28       Impact factor: 12.479

6.  Characterization of lymphangiogenesis in a model of adult skin regeneration.

Authors:  Joseph M Rutkowski; Kendrick C Boardman; Melody A Swartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-28       Impact factor: 4.733

7.  Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells.

Authors:  Borhane Annabi; Eric Vaillancourt-Jean; Alexander G Weil; Richard Béliveau
Journal:  Onco Targets Ther       Date:  2010-11-15       Impact factor: 4.147

8.  Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays.

Authors:  David G Belair; Michael P Schwartz; Thomas Knudsen; William L Murphy
Journal:  Acta Biomater       Date:  2016-05-13       Impact factor: 8.947

9.  The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice.

Authors:  Ravesanker Ezhilarasan; Unmesh Jadhav; Indra Mohanam; Jasti S Rao; Meena Gujrati; Sanjeeva Mohanam
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

Review 10.  Mechanisms of angiogenesis in gliomas.

Authors:  O Kargiotis; J S Rao; A P Kyritsis
Journal:  J Neurooncol       Date:  2006-03-23       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.